21 related news articles for Influenza

Influenza expert, A/Prof Michelle Tate shares everything that you need to know for the 2023 flu season, including who is most at risk. …  Read more

Director’s message: For children with cancer, change starts here. Childhood cancer is rare but devastating and new treatment options are desperately needed. In the last four decades the US Food and Drug Authority (FDA) has approved 500 drugs for adult cancers but just 12 to treat childhood cancers.…  Read more

Hudson Institute research into treatments for severe influenza and pelvic organ prolapse have received funding in the Victorian Medical Research Acceleration grants 2023.…  Read more

The discovery of a new class of host-targeted therapy could give the medical profession a much-needed treatment option for serious flu infections.…  Read more

A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.…  Read more

Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

After two years of unusually low influenza infections due to social distancing, flu season 2022 is shaping up as a bad one for Australia. Influenza expert, Associate Professor Michelle Tate, answers some of the most frequently asked questions about flu and what we can expect in Australia this winter.…  Read more

A new anti-viral drug to target the cause of viral lung infections and the infection itself could be a game-changer in treating severe influenza.…  Read more

Leading virus scientist, Associate Professor Michelle Tate explains why new treatments are needed alongside vaccines.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.…  Read more

A drug used in WW II to treat inflammation may hold the key to saving lives in the fight against flu deaths.…  Read more

Influenza expert Dr Michelle Tate answers frequently asked questions about the flu and addresses misconceptions that often come up in conversation during the winter months.…  Read more

Two Hudson Institute scientists, Dr Michelle Tate and Dr Erin McGillick, have been presented with prestigious Victorian Young Tall Poppy Science Awards in recognition of their outstanding research achievements and community engagement.…  Read more

Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

There have been more than 2.5 times the number of laboratory confirmed cases of flu (160,000) in Australia compared with the same period last year. The effects of a bumper flu season are still being felt well into spring, with moderate levels of flu activity expected to linger into October. Around 800 people die from the…  Read more

Emerging leader in viral pathogenesis and immunology, Dr Michelle Tate has received a promotion to lead her own research group within the Centre for Innate Immunity and Infectious Diseases. Dr Tate’s research group, ‘Viral immunity and immunopathology’ will focus on the understanding the induction of hyperinflammation during an influenza virus infection. “My research aims to…  Read more

Hudson Institute of Medical Research researchers have been awarded National Health and Medical Research Council Fellowships in the latest funding announcements.…  Read more

Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.…  Read more

A team of researchers at Hudson Institute of Medical Research have found that timely blocking of the body’s own immune response to infection from a severe or pathogenic strain of influenza could be vital in treating patients infected during a global pandemic.…  Read more